We are Thrilled to Announce that Cell and Gene Therapy Expert and Entrepreneur, Dana Hammill, has Joined the Tactix Team as Life Sciences Advisor

January 23, 2023

Tactix continues to build upon its expertise in life sciences real estate with the hiring of Dana Hammill as Life Sciences Advisor. Dana is an accomplished cell and gene therapy expert and entrepreneur. She brings over 25 years of experience in translational and clinical research to the Tactix advisory team, specifically in cell and gene therapies, as well as extensive experience with start-ups, incubations and fund raising.

“Tactix has always been a major player in life sciences real estate including major laboratory/headquarters projects for companies like West Pharmaceutical Services, Incyte, Shire, Imvax, Optinose, NutPathe, and Biomeme” said Ryan Conner, a principal of Tactix. “Now, with Dana, we will be able to provide a whole new level of expertise and understanding that very few brokerage firms can provide.”

“Dana not only understands the underlying science these companies are developing, but she also has firsthand knowledge of the operational, regulatory, and funding challenges they are facing. Her background and expertise will be invaluable to us and our clients in structuring the best real estate solutions,” said Glenn Blumenfeld, CEO of Tactix.

Dana’s journey in cell and gene therapies began in 1998 at Penn Medicine’s Institute for Human Gene Therapy under the direction of Dr. James Wilson. After Penn, she was a Director at the University City Science Center helping catalyze the Philadelphia region’s start-ups with management, real estate sourcing and procurement, and fund raising. As an independent consultant, she supported Large Pharma’s Phase III world-wide clinical trials for several years before returning to academia. Back at Penn, Dana was the Director of Strategy and Business Development for the Center for Cellular Immunotherapies at the Perelman School of Medicine. Notably in this role, Ms. Hammill served on the finance committee and managed the Penn-Novartis alliance including the process of obtaining FDA approval of the first CAR T cell therapy in the United States.

Dana said, “I am thrilled to be associating with Tactix. I first worked with Tactix when I was Chief Operating Officer at DeCART Therapeutics, a company I co-founded with Dr. Carl June, and was so impressed by their real estate knowledge, sophistication and dedicated tenant advocacy. Combining my strong life sciences background and experience with their renowned real estate expertise, we are going to be able to provide life sciences companies with a value proposition they can’t get anywhere else.”

About Tactix Real Estate Advisors: Tactix is the premier commercial real estate brokerage firm in Greater Philadelphia committed exclusively to representing tenants and owner-occupiers with their real estate decisions. The Tactix team is comprised of uniquely skilled and experienced professionals with strong real estate and business backgrounds including former real estate lawyers, MBAs, and finance and real estate professionals, many of whom have advanced degrees in real estate related fields. Tactix helps its clients develop and execute tailor-made real estate acquisition, leasing and management strategies that support their unique goals and objectives, resulting in cost-savings and exceptional business performance. Clients include companies of all sizes, both public and private, ranging from large, established Fortune 500 companies to small entrepreneurial firms, law, accounting and other professional service firms, universities, healthcare systems, other institutions and nonprofits, life science companies, warehousing companies, manufacturers and more.


More News and Highlights